A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. (Q51746413)
Jump to navigation
Jump to search
scientific article published in February 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. |
scientific article published in February 2018 |
Statements
1 reference
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. (English)
1 reference
Jonathan D Finn
1 reference
Amy Rhoden Smith
1 reference
Mihir C Patel
1 reference
Lucinda Shaw
1 reference
Madeleine R Youniss
1 reference
Jane van Heteren
1 reference
Tanner Dirstine
1 reference
Corey Ciullo
1 reference
Reynald Lescarbeau
1 reference
Jessica Seitzer
1 reference
Ruchi R Shah
1 reference
Aalok Shah
1 reference
Dandan Ling
1 reference
Jacqueline Growe
1 reference
Melissa Pink
1 reference
Ellen Rohde
1 reference
Kristy M Wood
1 reference
William E Salomon
1 reference
William F Harrington
1 reference
Christian Dombrowski
1 reference
Walter R Strapps
1 reference
Yong Chang
1 reference
David V Morrissey
1 reference
1 February 2018
1 reference
1 reference
22
1 reference
2227-2235
1 reference
9
1 reference
Identifiers
1 reference